INFORMACIONES PSIQUIÁTRICAS 247

Informaciones Psiquiátricas 2022 - n.º 247 97 nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 1996; 53: 1022–31 29. Sartorius N. Preface. In: Sartorius N, Schulze H, eds. Reducing the stigma of mental illness; a report from the global program- me of the World Psychiatric Association. Cambridge: Cambridge University Press, 2005: xi–xii. 30. Di Forti M, Quattrone D, Freeman TP, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry 2019; 6: 427–36. 31. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychia- try 2011; 70: 672–79. 32. Zanelli J, Mollon J, Sandin S, et al. Cognitive change in schi- zophrenia and other psychoses in the decade following the first episode. Am J Psychiatry 2019; 176: 811–19. 33. Varese F, Smeets F, Drukker M, et al. Childhood adversities in- crease the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull 2012; 38: 661–71. 34. Baldwin JR, Reuben A, Newbury JB, Danese A. Agreement bet- ween prospective and retrospective measures of childhood maltreatment: a systematic review and meta-analysis. JAMA Psychiatry 2019; 76: 584–93. 35. Correll CU, Galling B, Pawar A, et al. Comparison of early inter- vention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry 2018; 75: 555–65 SCHIZOPHRENIA